ATP5IF1 and carcinoma: Remarkably, the overexpression of IF1 in hepatocarcinomas48, gastric49, lung50 and bladder51 carcinomas and gliomas52 identifies patients with worst prognosis because IF1 favors proliferation and metastatic disease.